<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02465684</url>
  </required_header>
  <id_info>
    <org_study_id>UKA-Tourniquet</org_study_id>
    <nct_id>NCT02465684</nct_id>
  </id_info>
  <brief_title>Effect of Tourniquet on UKA</brief_title>
  <official_title>The Role of a Thigh Tourniquet in Unicondylar Knee Arthroplasty: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University Linz, Austria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University Innsbruck</source>
  <brief_summary>
    <textblock>
      There is obviously a lack of evidence regarding the risk-benefit ratio of a thigh tourniquet
      in unicondylar knee arthroplasty (UKA). This refers to many possible outcome criteria like
      operating time, blood loss, quality of prosthesis fixation in the bone, adverse events,
      radiographic result, clinical score outcome, easy of rehabilitation etc. It is not
      appropriate to rely on findings from the field of total knee arthroplasty.

      It is the aim of the current study, to clarify the role of a thigh tourniquet during UKA with
      regard to component fixation quality, component positioning and sizing, clinical outcome and
      rehabilitation process.

      Patients scheduled for routine UKA implantation due to osteoarthritis or osteonecrosis in the
      medial compartment will be considered for participation.

      Patients are then randomized for surgery with or without tourniquet. After an anteromedial
      Quad-Sparing approach the UKA procedure itself is then carried out, as suggested by the
      manufacturer. For both groups puls lavage and meticulous drying is applied before cementing.

      The following outcome parameters are assessed: 1)radiographic cement mantle thickness,
      2)component position &amp; sizing, 3)diolucencies, 4)score outcome and 5)parameters of early
      Rehab.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2016</start_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cement mantle thickness</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Tourniquets</condition>
  <condition>Arthroplasty</condition>
  <arm_group>
    <arm_group_label>tourniquet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>UKA surgery with tourniquet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no tourniquet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>UKA without tourniquet</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>unicondylar knee arthroplasty</intervention_name>
    <arm_group_label>tourniquet</arm_group_label>
    <arm_group_label>no tourniquet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  waiting list for unicondylar knee arthroplasty

        Exclusion Criteria:

          -  failed upper tibial osteotomy,

          -  insufficiency of the collateral or anterior cruciate ligaments,

          -  a fixed varus or valgus deformity (not passively correctable) above 15°,

          -  a flexion deformity greater than 15° and 5) rheumatoid arthritis. In addition - with
             regard to the scope of the current study - further exclusion criteria will be

          -  intake of medicinal anticoagulation prior to surgery

          -  liver dysfunction / coagulation dysfunction

          -  peripheral arterial obstructive disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Liebensteiner, Assoc. Prof.</last_name>
    <phone>+43 512 50480547</phone>
    <email>michael.liebensteiner@i-med.ac.at</email>
  </overall_contact>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2015</study_first_submitted>
  <study_first_submitted_qc>June 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2015</study_first_posted>
  <last_update_submitted>July 16, 2016</last_update_submitted>
  <last_update_submitted_qc>July 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University Innsbruck</investigator_affiliation>
    <investigator_full_name>Michael Liebensteiner</investigator_full_name>
    <investigator_title>Michael Liebensteiner MD, PhD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

